Although there are several systematic reviews evaluating the relationship between several adipocytokines and risk of CRC or CRA, including leptin and adiponectin [16–20], to the best of our knowledge, there is no meta-analysis on the associations of circulating resistin and CRC. The gene discussed is ADIPOQ; the disease is colorectal carcinoma.